NASDAQ:PRCT PROCEPT BioRobotics (PRCT) Stock Price, News & Analysis $61.87 -2.53 (-3.93%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$61.53▼$65.4450-Day Range$58.09▼$71.2352-Week Range$24.83▼$77.00Volume763,720 shsAverage Volume552,339 shsMarket Capitalization$3.18 billionP/E RatioN/ADividend YieldN/APrice Target$62.60 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get PROCEPT BioRobotics alerts: Email Address PROCEPT BioRobotics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1.2% Upside$62.60 Price TargetShort InterestBearish11.30% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.74Based on 5 Articles This WeekInsider TradingSelling Shares$5.52 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.93) to ($1.48) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.75 out of 5 starsMedical Sector862nd out of 936 stocksSurgical & Medical Instruments Industry93rd out of 101 stocks 1.5 Analyst's Opinion Consensus RatingPROCEPT BioRobotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoveragePROCEPT BioRobotics has only been the subject of 3 research reports in the past 90 days.Read more about PROCEPT BioRobotics' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.30% of the float of PROCEPT BioRobotics has been sold short.Short Interest Ratio / Days to CoverPROCEPT BioRobotics has a short interest ratio ("days to cover") of 8.9.Change versus previous monthShort interest in PROCEPT BioRobotics has recently increased by 8.53%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldPROCEPT BioRobotics does not currently pay a dividend.Dividend GrowthPROCEPT BioRobotics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRCT. Previous Next 3.2 News and Social Media Coverage News SentimentPROCEPT BioRobotics has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for PROCEPT BioRobotics this week, compared to 3 articles on an average week.Search InterestOnly 9 people have searched for PRCT on MarketBeat in the last 30 days. This is a decrease of -10% compared to the previous 30 days.MarketBeat Follows5 people have added PROCEPT BioRobotics to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PROCEPT BioRobotics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,515,482.00 in company stock.Percentage Held by Insiders17.40% of the stock of PROCEPT BioRobotics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions89.46% of the stock of PROCEPT BioRobotics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PROCEPT BioRobotics' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for PROCEPT BioRobotics are expected to grow in the coming year, from ($1.93) to ($1.48) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PROCEPT BioRobotics is -29.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PROCEPT BioRobotics is -29.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPROCEPT BioRobotics has a P/B Ratio of 11.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about PROCEPT BioRobotics' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About PROCEPT BioRobotics Stock (NASDAQ:PRCT)PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.Read More PRCT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRCT Stock News HeadlinesJuly 25 at 3:38 AM | americanbankingnews.comPROCEPT BioRobotics (PRCT) Scheduled to Post Quarterly Earnings on ThursdayJuly 24 at 11:48 AM | finance.yahoo.comWith 84% ownership of the shares, PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is heavily dominated by institutional ownersJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 16, 2024 | americanbankingnews.comPROCEPT BioRobotics (NASDAQ:PRCT) Price Target Increased to $79.00 by Analysts at Truist FinancialJuly 15, 2024 | globenewswire.comPROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024June 27, 2024 | investorplace.comYou've Been Warned! 3 Robotics Stocks to Buy Now or Regret Forever.June 17, 2024 | globenewswire.comPROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapyJune 3, 2024 | globenewswire.comPROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 17, 2024 | finance.yahoo.comIntuitive Surgical, IBD Stock Of The Day, Feels Its Way Toward Buy PointMay 13, 2024 | globenewswire.comPROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock ConferenceMay 6, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Fulgent Genetics (FLGT), Cigna (CI) and PROCEPT BioRobotics (PRCT)May 6, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and PROCEPT BioRobotics (PRCT)May 6, 2024 | markets.businessinsider.comUnveiling 4 Analyst Insights On PROCEPT BioRoboticsMay 6, 2024 | globenewswire.comReal-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic HyperplasiaMay 4, 2024 | finance.yahoo.comPROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported And Analysts Have Been Lifting Their Price TargetsMay 3, 2024 | finance.yahoo.comPROCEPT BioRobotics First Quarter 2024 Earnings: Beats ExpectationsMay 3, 2024 | finance.yahoo.comPROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2024 Earnings Call TranscriptSee More Headlines Receive PRCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PROCEPT BioRobotics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/01/2024Today7/26/2024Next Earnings (Confirmed)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:PRCT CUSIPN/A CIK1588978 Webwww.procept-biorobotics.com Phone650-232-7200FaxN/AEmployees430Year FoundedN/APrice Target and Rating Average Stock Price Target$62.60 High Stock Price Target$79.00 Low Stock Price Target$37.00 Potential Upside/Downside-0.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($2.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-105,900,000.00 Net Margins-66.12% Pretax Margin-66.12% Return on Equity-41.35% Return on Assets-27.92% Debt Debt-to-Equity Ratio0.19 Current Ratio8.52 Quick Ratio7.44 Sales & Book Value Annual Sales$136.19 million Price / Sales23.79 Cash FlowN/A Price / Cash FlowN/A Book Value$5.56 per share Price / Book11.33Miscellaneous Outstanding Shares51,420,000Free Float42,476,000Market Cap$3.24 billion OptionableOptionable Beta1.00 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Reza Zadno Ph.D. (Age 69)President, CEO & Director Comp: $1.13MMr. Kevin Waters (Age 47)Executive VP & CFO Comp: $680.11kMs. Alaleh Nouri (Age 45)EVP, Chief Legal Officer & Corporate Secretary Comp: $605.84kMr. Hisham Shiblaq (Age 48)Executive VP & Chief Commercial Officer Comp: $645.95kMr. Mohan F. Sancheti (Age 60)Senior Vice President of Operations Mr. Barry TemplinExecutive VP of Technology & Clinical DevelopmentMr. Matthew James Bacso C.F.A.Vice President of Investor RelationsMs. Stacey L. Porter (Age 48)Chief People Officer Mr. Bijesh ChandranSenior Vice President of Regulatory Affairs & Quality AssuranceMore ExecutivesKey CompetitorsAtrionNASDAQ:ATRIInogenNASDAQ:INGNBionano GenomicsNASDAQ:BNGOCuteraNASDAQ:CUTRVapothermNYSE:VAPOView All CompetitorsInsiders & InstitutionsAllspring Global Investments Holdings LLCSold 11,422 shares on 7/26/2024Ownership: 0.365%Legato Capital Management LLCBought 9,701 shares on 7/26/2024Ownership: 0.100%Bailard Inc.Sold 3,000 shares on 7/26/2024Ownership: 0.036%AlphaCentric Advisors LLCSold 15,000 shares on 7/26/2024Ownership: 0.019%RiverPark Advisors LLCBought 2,211 shares on 7/26/2024Ownership: 0.004%View All Insider TransactionsView All Institutional Transactions PRCT Stock Analysis - Frequently Asked Questions How have PRCT shares performed this year? PROCEPT BioRobotics' stock was trading at $41.91 at the start of the year. Since then, PRCT stock has increased by 47.6% and is now trading at $61.87. View the best growth stocks for 2024 here. How were PROCEPT BioRobotics' earnings last quarter? PROCEPT BioRobotics Co. (NASDAQ:PRCT) issued its quarterly earnings data on Wednesday, May, 1st. The company reported ($0.51) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.55) by $0.04. PROCEPT BioRobotics's quarterly revenue was up 82.4% on a year-over-year basis. When did PROCEPT BioRobotics IPO? PROCEPT BioRobotics (PRCT) raised $126 million in an IPO on Wednesday, September 15th 2021. The company issued 5,500,000 shares at a price of $22.00-$24.00 per share. Who are PROCEPT BioRobotics' major shareholders? Top institutional investors of PROCEPT BioRobotics include Bank of New York Mellon Corp (0.59%), Allspring Global Investments Holdings LLC (0.36%), M&G Plc (0.27%) and Legato Capital Management LLC (0.10%). Insiders that own company stock include Frederic H Moll, Reza Zadno, Morgan Colby Wood, Kevin Waters, Hisham Shiblaq, Alaleh Nouri and Global Investors Lp Viking. View institutional ownership trends. How do I buy shares of PROCEPT BioRobotics? Shares of PRCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRCT) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
